-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the international academic journal Carbohydrate Polymers reported that Zhang Quanbin’s research group from the Key Laboratory of Experimental Marine Biology of the Chinese Academy of Sciences reported that low-molecular-weight fucoidan sulfate reduces the body’s inflammatory response and inhibits the transfer of cell epithelial to mesenchymal lobes, thereby inhibiting the occurrence and development of pulmonary fibrosis.
Quanbin Zhang’s research team has been committed to the preparation and functional research of fucoidan sulfate for many years.
LMWF inhibits bleomycin ( BLM )-induced lung fibrosis in mice
Analysis of the molecular mechanism of LMWF inhibiting the process of pulmonary fibrosis
Associate researcher Wu Ning is the first author and corresponding author of the paper, PhD student Li Zhi is the co-first author of the paper, and researcher Zhang Quanbin is the co-corresponding author of the paper
Ning Wu #* ,Zhi Li # , Jing Wang, Lihua Geng, Yang Yue, Zhenzhen Deng, Qingchi Wang, Quanbin Zhang* .
DOI: https://doi.
Link to the paper: https://